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Abstract
Background: Microdeletions on chromosome 17q12 cause of diverse spectrum of disorders and have only recently
been identified as a rare cause of Mayer-Rokitansky-Kuester-Hauser-Syndrome (MRKH), which is characterized by
uterus aplasia ± partial/complete vaginal aplasia in females with a regular karyotype. For the first time we report
about a patient with a 17q12 microdeletion who is affected by MRKH in combination with a vascular and soft
tissue disorder. Repeatedly she suffered from kidney transplant failure caused by consuming membranous
nephropathy.
Case presentation: A 38-year-old female patient had been diagnosed with right kidney aplasia, left kidney
dysplasia and significantly impaired renal function during infancy. Aged 16 she had to start hemodialysis. Three
years later she received her first kidney transplant. Only then she was diagnosed with MRKH. The kidney transplant
was lost due to consuming nephrotic syndrome caused by de novo membranous nephropathy, as was a second
kidney transplant years later. In addition, a hyperelasticity syndrome affects the patient with congenital joint laxity,
kyphoscoliosis, bilateral hip dysplasia, persistent hypermobility of both elbows, knees and hips. Her clinical picture
resembles a combination of traits of a hypermobile and a vascular form of Ehlers-Danlos-Syndrome, but no
mutations in the COL3A1 gene was underlying. Instead, array-based comparative genomic hybridisation (CGH)
detected a heterozygous 1.43 Mb deletion on chromosome 17q12 encompassing the two renal developmental
genes HNF1β and LHX1.
Conclusions: Deletions of HNF1β have recently drawn significant attention in pediatric nephrology as an important
cause of prenatally hyperechogenic kidneys, renal aplasia and renal hypodysplasia. In contrast, membranous
nephropathy represents an often-unaccounted cause of nephrotic syndrome in the adult population. A causative
connection between theses two conditions has never been postulated, but is suggestive enough in this case to
hypothesize it.
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Background
Microdeletions on chromosome 17q12 encompassing
the hepatocyte nuclear factor 1β (HNF1β) have recently
been characterized as an important cause of prenatally
hyperechogenic kidneys, renal aplasia and renal hypo-
dysplasia, which represent an important cause of chronic
renal failure among children [1,2]. The following case
expands the diverse spectrum of disorders associated
with 17q12 microdeletions and reveals a hypothetical
link with membranous nephropathy (MN), a common
and often unaccounted cause of nephrotic syndrome in
the adult population.
Case presentation
A now 38-year-old female patient was born as the third
of four daughters of healthy parents. Her oldest sister
remains healthy, while her second oldest sister suffers
from idiopathic focal epilepsy and her youngest sister
from Prader-Willi-Syndrome caused by a maternal par-
ental disomy on chromosome 15. Following a regular
pregnancy our patient first presented with a pyeloneph-
ritis at the age of four months. Right kidney aplasia and
a significantly impaired renal function (serum creatinine
1.9 mg/dl, urea 83 mg/dl) were then noted, already indi-
cating dysplasia of the left kidney. Her female external
genitalia showed no anomalies and cystoscopy documen-
ted the presence of bilateral ureters. Over the following
years chronic renal failure progressed as recurrent urin-
ary tract infections occurred. Finally, she was referred to
a pediatric nephrology unit at the age of 10 years and
started hemodialysis six years later with a serum creatin-
ine of 6 mg/dl. Aged 19 she received her first kidney
transplant without any complications. As primary amen-
orrhea had persisted while pubertal development was
commensurate with age, a diagnostic laparoscopy was
undertaken and revealed a rudimentary uterus and regu-
lar ovaries. On the basis of a normal 46/XX karyotype
the diagnosis of atypical Mayer-Rokitansky-Kuester
-Hauser-Syndrome (i.e. MRKH Type II) was made. Aged
28 her first kidney transplant was lost due to consuming
nephrotic syndrome caused by biopsy-proven de novo
MN. At the age of 36 a second kidney transplantation
was performed. Despite thymoglobulin induction and an
intensified triple immunosuppressive therapy (tacroli-
mus, mycophenolate mofetil, prednisolone), under which
she developed new onset diabetes mellitus after trans-
plantation (NODAT), MN reoccurred within only four
weeks after transplantation. Testing for secondary causes
of MN such as hepatitis, HIV and antibodies against the
phospholipase-A2 receptor (PLA2R) was negative [3].
All attempts to reverse MN including high dose steroids,
immunoglobulin, plasma- and immunoabsorption, anti-
CD20-antibodies (Rituximab) and proteasome inhibitor
(Bortezomib) failed. Finally, the transplant had to be
explanted despite remaining renal function (creatinine
2.4 mg/dl) due to the severity of nephrotic syndrome
(albuminuria ≤ 15 g/g creatinine; Figure 1).
In addition to her urogenital anomalies our patient is
affected by a hyperelasticity syndrome with congenital
joint laxity, kyphoscoliosis, and bilateral hip dysplasia.
She shows persistent hypermobility of both elbows and
knees and is easily able to place her feet behind her
head, all of which are very unusual findings in a long-
standing dialysis patient (Figure 2a-c). Her Beighton
score is currently 8/9. As a result of dilating hyperelastic
vascular walls arterio-venous fistulas on both arms rap-
idly developed hyperdynamic flows. Repeated surgical
banding of the fistulas accomplished only a temporary
improvement, so that vascular access was ligated shortly
after transplantation to control right heart failure with
tricuspid valve insufficiency (Figure 2d).
In summary, this clinical picture resembles a mixture
between a hypermobile (EDS3) and a vascular (EDS4)
form of Ehlers-Danlos-Syndrome (EDS). Mutation ana-
lysis of the collagen type 3 alpha 1 gene (COL3A1),
which is mutated in EDS4 and rarely in EDS3, was nega-
tive. We did not analyze tenascin-X (TNXB), another
rare cause of EDS3, because characteristic hyperelastic
skin changes were missing in our case. Mutations in the
FBN1 gene, which is mutated in Marfan syndrome, had
been excluded previously. As a next step a skin biopsy
was taken for electron microscopy. It revealed a soft tis-
sue disorder with loosely packed collagen fibres. The
picture resembled findings in EDS4, without meeting the
obligatory criteria of this disease, and was not suggestive
of any other form of EDS.
We therefore performed an array-based comparative
genomic hybridisation (CGH) and detected a heterozy-
gous 1.43 Mb deletion on chromosome 17q12 (Figure 3).
This deletion contained sixteen RefSeq genes and was ab-
sent in both the father and the mother of our patient, con-
sistent with a de novo copy number variant (CNV).
Conclusions
Mayer-Rokitansky-Kuester-Hauser (MRKH) is a quite
common inherited condition (1:4.000-5.000) characterized
by uterus aplasia ±partial/complete vaginal aplasia in
females with a regular karyotype XX/46 and physiological
ovarial function [4-6]. Microdeletions of chromosome
17q12 including HNF1β, such as the one detected in this
case have recently been identified as a rare cause of MRKH
[4-6]. In a series of only five published cases, three women
presented without (MRKH type I/typical) and two with
kidney affection (MRKH type II/atypical). This finding
reflects the highly variable clinical picture of even identical
17q12 microdeletions, reaching from diabetes (MODY5 or
NODAT, as observed in our patient), to pancreas and liver
anomalies, epilepsy, sensorineural hearing loss, cognitive
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impairment, autism and even schizophrenia [7-10]. Our
patient has no neurological impairments and works as a
teacher. Nevertheless, in addition to previously reported
cases, she is affected by a soft tissue disorder with joint
hypermobility and vascular hyperelasticity resembling a
picture with features of both the hypermobile (EDS3) and
the vascular (EDS4) form Ehlers-Danlos-Syndrome. We
observed structural collagen changes of the skin in electron
and light microscopy and excluded mutations in COL3A1.
A causative genetic defect in another unknown locus is
thereby not excluded. However, joint laxity has been
described in selected individuals with deletions on 17q12
Figure 2 Vascular and soft tissue disorder of the patient with hypermobility of both elbows (a) and hips (b). Hyperdynamic arterio-venous
fistulas on both arms (c) led to tricuspid valve insufficiency and required ligation, which resulted in a rapid decline of the significantly raised brain
natriuretic peptide (BNP) (d).
Figure 1 Percutaneous kidney biopsy four weeks after the second kidney transplantation revealed de-novo MN and moderate tubulo-
interstitial changes (a) and granular pseudolinear deposition of immunoglobulin G (IgG) along the epithelial surface of the glomerular
basement membrane (GBM) (b). C3c-deposits along the GBM of the patient were present (c). In reverse, incubation of human kidney samples
with serum from the patient showed immunofluorescent staining of the GBM, documenting the presence of anti-human-GBM alloantibodies in
the patient (d).
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(DECIPHER patients 248627, 249204) and could result
from the microdeletion itself.
Following kidney transplantation our patient repeatedly
developed MN, a major cause of nephrotic syndrome in
adults. We excluded secondary causes of MN and detected
no PLA2R autoantibodies, which are found in approxi-
mately 75% of all cases of “idiopathic” MN in the adult
population [3]. The identification of further glomerular
components as targets for autoantibodies in MN has been
suggested [3]. Our patient developed MN and consuming
nephrotic syndrome years after her first, but only weeks
after her second kidney transplantation. This clinical course
may reflect a boostered alloimmune response against the
kidney transplants, or alternatively a boostered response
against a physiological glomerular epitope, which had not
been expressed in the patient’s native kidney. Consistent
with the second assumption, incubation of renal tissue spe-
cimens from healthy human controls with the patients’
serum resulted in granular deposits of immunoglobulin G
(IgG) along the surface of the glomerular basement mem-
brane (Figure 1d). Staining of respective mouse and rat kid-
ney samples was negative. No candidate gene encoding a
structural component of the glomerular filtration barrier as
a hypothetical antibody target is located within the micro-
deletion on 17q12. Still, it is remarkable that the deletion
includes two transcription factors, which are important in
kidney development. HNF1β and LHX1 are physically adja-
cent genes on 17q12. Their gene products are involved in
one signaling pathway in which HNF1β directly activates
the promotor of LHX1 [11]. LHX1 is a major and dose-
dependent regulator of various steps of renal and urogenital
development. In the kidney LHX1 is required for epithelial
tubular genesis and for podocyte development, including
the crucial morphogenic step of the glomerulus from a
comma to an S-shape stage and consecutively for the devel-
opment of the glomerular filtration barrier [12,13]. The
significance of LHX1 in human disease remains an open
question and it will be interesting to observe if eventually a
connection between alterations of LHX1 and cases of mem-
branous nephropathy such as ours can be demonstrated.
Above all, our case illustrates how recent molecular
findings in inborn orphan disease may permit the diag-
nosis for complex phenotypes in adult patients - a cir-
cumstance which was truly appreciated by our patient
38 years after her first clinical presentation.
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Figure 3 The heterozygous 1.43 Mb deletion arr 17q12(34.817.222-36.249.059)x1 (ISCN 2009, GRCh37/hg19) containing the sixteen RefSeq
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